Literature DB >> 11102556

Expression of wild-type and mutant human ornithine transcarbamylase genes in Chinese hamster ovary cells and lack of dominant negative effect of R141Q and R40H mutants.

L Augustin1, M Mavinakere, H Morizono, M Tuchman.   

Abstract

Chinese hamster ovary cultured cells were transformed to continuously express wild-type and two mutant ornithine transcarbamylase genes, R141Q and R40H. In addition, these cells were transfected to transiently express the same genes. The R141Q mutation abolishes the enzymatic activity, and the amount of "mature" protein present in transfected cells is equivalent to the wild type. The R40H mutation causes a reduction of enzymatic activity to approximately 26 to 35% of wild type concomitant with a significant reduction in the amount of protein present. Transfection with wild-type and mutant genes together in various proportions did not reveal dominant negative effects of the two mutations studied. This expression system can be used to examine the deleterious effect of private mutations or lack thereof in families with ornithine transcarbamylase deficiency as well as evaluate the potential dominant negative effects of gene delivery for treatment of ornithine transcarbamylase deficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11102556     DOI: 10.1203/00006450-200012000-00023

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  5 in total

1.  Two novel mutations of ornithine transcarbamylase gene identified from three Chinese neonates with ornithine transcarbamylase deficiency.

Authors:  Jing Liu; Lei Dong; Yan Wang; Mei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.

Authors:  Ljubica Caldovic; Iman Abdikarim; Sahas Narain; Mendel Tuchman; Hiroki Morizono
Journal:  J Genet Genomics       Date:  2015-05-19       Impact factor: 4.275

3.  The clinically variable R40H mutant ornithine carbamoyltransferase shows cytosolic degradation of the precursor protein in CHO cells.

Authors:  M Mavinakere; H Morizono; D Shi; N M Allewell; M Tuchman
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

4.  A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.

Authors:  Yang Yang; Lili Wang; Peter Bell; Deirdre McMenamin; Zhenning He; John White; Hongwei Yu; Chenyu Xu; Hiroki Morizono; Kiran Musunuru; Mark L Batshaw; James M Wilson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

5.  Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity.

Authors:  Mónica Lopes-Marques; Ana Rita Pacheco; Maria João Peixoto; Ana Rita Cardoso; Catarina Serrano; António Amorim; Maria João Prata; David N Cooper; Luísa Azevedo
Journal:  Hum Mutat       Date:  2021-06-03       Impact factor: 4.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.